In short

Yes, for many people. The maintenance dose is where the trials concentrated, not a threshold below which nothing happens. If you are responding well and.

By Alsen Walker · Updated October 8, 2026

By Alsen Walker · Editorially reviewed on 25 August 2026 · Not medically reviewed by a clinician

Yes, for many people. The maintenance dose is where the trials concentrated, not a threshold below which nothing happens. If you are responding well and tolerating a lower dose, staying there is a legitimate clinical option, and it is a conversation with your prescriber rather than a decision either of you should make by default.

This is a discussion, not a decision to take alone. Do not hold at a dose without telling your prescriber. It affects what they expect to see, and for people treated for diabetes or cardiovascular risk the target dose may matter more than it does for weight alone.

For how this fits into the wider titration picture, see GLP-1 Dosing and Titration: The Complete Guide.

Where the maintenance dose comes from

Trials establish efficacy and safety at particular doses, and the maintenance dose is the one carried through those studies. That makes it the best-evidenced dose, not the only one that works.

Response varies considerably between people. Some get most of their effect early in the titration; others need the full dose to see much at all. Neither is unusual.

Good reasons to stay lower

Side effects that were manageable at your current dose and were not at the next one. This is the most common reason and a perfectly sound one.

Responding well already, with weight moving at a rate you and your prescriber are content with.

Losing faster than is comfortable or than is advisable, where a lower dose slows things to a better pace.

Cost, in some situations, though this depends on how the product is priced and dispensed and is worth checking rather than assuming a lower dose is cheaper.

Where it matters more to reach the target

If you are being treated for type 2 diabetes, cardiovascular risk reduction or sleep apnea rather than weight alone, the dose studied for that indication carries more weight in the decision.

The benefit in those settings was demonstrated at particular doses, and a lower one is less well evidenced for that specific purpose. Your prescriber will factor this in, and it is worth understanding why the answer may differ from a purely weight-focused one.

The insurance angle

Continuation criteria usually look at documented response rather than at what dose you are taking, so staying lower is not normally a coverage problem in itself.

Mention any plan requirements when you discuss it, though, since criteria vary and it is easier to check in advance than to unpick a refused renewal.

How to have the conversation

Bring the evidence rather than the preference. What your weight has done at this dose. How you are tolerating it. What happened when you tried to step up, if you did. What you are aiming for.

Ask directly whether staying here is reasonable given what you are being treated for, and what would change their mind either way.

It is not permanent either

Holding at a dose does not close the door. If your response slows later, or your circumstances change, stepping up remains available.

Equally, if a lower dose stops being enough, that is information rather than failure.

Where you are treated for diabetes, cardiovascular risk or sleep apnea rather than weight alone, the target dose matters more, as the SELECT trial and the sleep apnea indication explain. For the maintenance version of this question, see maintenance dosing after goal weight.

Frequently asked questions

Will a lower dose stop working over time?
Weight loss slows as you get lighter regardless of dose. That is usually energy balance rather than the dose failing.

Is a lower dose safer?
Fewer side effects for many people. The serious warnings apply across the dose range, so it is not a way of avoiding those.

Can I go up later if I change my mind?
Yes, with your prescriber. Expect an adjustment period when you do.

Does staying low mean I need it forever anyway?
Duration is a separate question from dose, and worth discussing on its own terms.

Will my prescriber think I am not committed?
Unlikely. Tolerability-led dosing is ordinary practice and the conversation is a normal one.

Is it cheaper?
Depends on the product and how it is supplied. Check rather than assume.

Sources and further reading

  1. Wilding JPH, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension. Diabetes Obes Metab. 2022. pubmed.ncbi.nlm.nih.gov
  2. MedlinePlus (US National Library of Medicine). Semaglutide injection: drug information. medlineplus.gov
  3. MedlinePlus (US National Library of Medicine). Tirzepatide injection: drug information. medlineplus.gov
  4. National Institute of Diabetes and Digestive and Kidney Diseases (NIH). Prescription medications to treat overweight and obesity. www.niddk.nih.gov

GLP1Hub content is for general information and is not medical advice. Prices and coverage rules change often, so confirm current details with the provider, your insurer and your prescriber. See our editorial standards and medical disclaimer.

More in Dosing & Titration

All Dosing & Titration guides →

Alsen Walker is a health writer and researcher at GLP1Hub with five years of experience researching and writing health and medical content. He works in a medical-field role alongside his undergraduate studies. At GLP1Hub he researches GLP-1 weight loss programs, pricing and insurance rules, and checks claims against FDA prescribing information, published clinical trials and official government sources. Alsen is not a physician, and his articles are general information, not medical advice.